Lai-Fong Poon

644 total citations
8 papers, 310 citations indexed

About

Lai-Fong Poon is a scholar working on Molecular Biology, Hematology and Physiology. According to data from OpenAlex, Lai-Fong Poon has authored 8 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Hematology and 3 papers in Physiology. Recurrent topics in Lai-Fong Poon's work include Acute Myeloid Leukemia Research (3 papers), Telomeres, Telomerase, and Senescence (3 papers) and Glycosylation and Glycoproteins Research (1 paper). Lai-Fong Poon is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), Telomeres, Telomerase, and Senescence (3 papers) and Glycosylation and Glycoproteins Research (1 paper). Lai-Fong Poon collaborates with scholars based in Singapore, United States and Australia. Lai-Fong Poon's co-authors include Jianbiao Zhou, Chien-Shing Chen, Senthilnathan Palaniyandi, Zhigang Xie, Keith B. Glaser, Steven K. Davidsen, Daniel H. Albert, Chonglei Bi, Hanry Yu and Viraj J. Jasinghe and has published in prestigious journals such as Nature Communications, Blood and Molecular and Cellular Biology.

In The Last Decade

Lai-Fong Poon

7 papers receiving 307 citations

Peers

Lai-Fong Poon

MB

HEMAT

ONCOL

PHYSI

GENET

Philip Berardi Canada

Kirthi Pulakanti United States

Alice Can Ran Qin United States

Riccardo Ronzoni Italy

Rajeswaran Mani United States

Zhenbiao Xia United States

Matthew F. Jones United States

Galia Oberkovitz Israel

Alessandra Rossi Italy

Candace J. Poole United States

Philip Berardi Canada

Lai-Fong Poon

248 ×1.3

MB

51 ×0.5

HEMAT

86 ×1.3

ONCOL

54 ×1.0

PHYSI

15 ×0.3

GENET

Citations per year, relative to Lai-Fong Poon Lai-Fong Poon (= 1×) peers Philip Berardi

Countries citing papers authored by Lai-Fong Poon

Since Specialization

Citations

This map shows the geographic impact of Lai-Fong Poon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lai-Fong Poon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lai-Fong Poon more than expected).

Fields of papers citing papers by Lai-Fong Poon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lai-Fong Poon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lai-Fong Poon. The network helps show where Lai-Fong Poon may publish in the future.

Co-authorship network of co-authors of Lai-Fong Poon

This figure shows the co-authorship network connecting the top 25 collaborators of Lai-Fong Poon. A scholar is included among the top collaborators of Lai-Fong Poon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lai-Fong Poon. Lai-Fong Poon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Tham, Cheng Yong, Lai-Fong Poon, Tingdong Yan, et al.. (2023). High-throughput telomere length measurement at nucleotide resolution using the PacBio high fidelity sequencing platform. Nature Communications. 14(1). 281–281. 27 indexed citations

2.

Ma, Dongliang, Tingdong Yan, Xiubo Fan, et al.. (2016). Distinct Responses of Stem Cells to Telomere Uncapping—A Potential Strategy to Improve the Safety of Cell Therapy. Stem Cells. 34(10). 2471–2484. 22 indexed citations

3.

Gopalakrishnan, Veena, et al.. (2013). Cdk1 Regulates the Temporal Recruitment of Telomerase and Cdc13-Stn1-Ten1 Complex for Telomere Replication. Molecular and Cellular Biology. 34(1). 57–70. 27 indexed citations

4.

Zhou, Jianbiao, Chonglei Bi, Shaw-Cheng Liu, et al.. (2009). Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML. Blood. 113(17). 4052–4062. 139 indexed citations

5.

Jasinghe, Viraj J., Zhigang Xie, Jianbiao Zhou, et al.. (2008). ABT-869, a multi-targeted tyrosine kinase inhibitor, in combination with rapamycin is effective for subcutaneous hepatocellular carcinoma xenograft. Journal of Hepatology. 49(6). 985–997. 31 indexed citations

6.

Xie, Zhigang, Peter Choong, Lai-Fong Poon, et al.. (2008). Inhibition of CD44 expression in hepatocellular carcinoma cells enhances apoptosis, chemosensitivity, and reduces tumorigenesis and invasion. Cancer Chemotherapy and Pharmacology. 62(6). 949–957. 45 indexed citations

7.

Zhou, Jianbiao, Viraj J. Jasinghe, Chonglei Bi, et al.. (2008). In vivo activity of ABT-869, a multi-target kinase inhibitor, against acute myeloid leukemia with wild-type FLT3 receptor. Leukemia Research. 32(7). 1091–1100. 19 indexed citations

8.

Zhou, Jianbiao, Chonglei Bi, Lai-Fong Poon, et al.. (2007). Overactivation of STAT Pathways and Overexpression of Survivin Confer Resistance to FLT3 Inhibitors and Could Be Therapeutic Targets in AML.. Blood. 110(11). 2367–2367.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact